Hepatocyte growth factor inhibits apoptosis by the profibrotic factor angiotensin II via extracellular signal-regulated kinase 1/2 in endothelial cells and tissue explants

Molecular Biology of the Cell

Volumn 21, Issue 23, 2010, Pages 4240-4250

  Lee, Young H ^a   Marquez, Ana P ^a   Mungunsukh, Ognoon ^a   Day, Regina M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CASPASE 3; CYTOCHROME C; LACTATE DEHYDROGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NUCLEOLIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL XL; SCATTER FACTOR;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DNA FRAGMENTATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME RELEASE; EXPLANT; HALF LIFE TIME; IMMUNOPRECIPITATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SECRETION; RAT; RNA STABILITY;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; CASPASE 3; CATTLE; CELL LINE; CYTOCHROMES C; DNA FRAGMENTATION; ENDOTHELIAL CELLS; HEPATOCYTE GROWTH FACTOR; IMMUNOPRECIPITATION; L-LACTATE DEHYDROGENASE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOPROTEINS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

RATTUS;

EID: 78650150619     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E10-04-0341     Document Type: Article

References (47)

1. Barel, M., Balbo, M., Le Romancer, M., and Frade, R. (2003). Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human cell surface triggers pp60src and Akt-GSK3 activities upstream and downstream to PI 3-kinase, respectively. Eur. J. Immunol. 33, 2557-2566.
2. Borgatti, P., Martelli, A. M., Tabellini, G., Bellacosa, A., Capitani, S., and Neri, L. M. (2003). Threonine 308 phosphorylated form of Akt translocates to the nucleus of PC12 cells under nerve growth factor stimulation and associates with the nuclear matrix protein nucleolin. J. Cell Physiol. 196, 79-88.
3. Bouche, G., Baldin, V., Belenguer, P., Prats, H., and Amalric, F. (1994). Activation of rDNA transcription by FGF-2, key role of protein kinase CKII. Cell. Mol. Biol. Res. 40, 547-554.
4. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., and Greenberg, M. E. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868.
5. Day, R. M., Cioce, V., Breckenridge, D., Castagnino, P., and Bottaro, D. P. (1999). Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis. Oncogene 18, 3399-3406. (Pubitemid 29286986)
6. del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R., and Nunez, G. (1997). Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687-689. (Pubitemid 27464966)
7. Dohi, M., Hasegawa, T., Yamamoto, K., and Marshall, B. C. (2000). Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 162, 2302-2307.
8. Ebina, M., Shimizukawa, M., Narumi, K., Miki, M., Koinuma, D., Watabe, M., Munakata, H., and Nukiwa, T. (2002). Towards an effective gene therapy for idiopathic pulmonary fibrosis. Chest 121, 32S-33S.
9. Fan, S., Ma, Y. X., Wang, J. A., Yuan, R. Q., Meng, Q., Cao, Y., Laterra, J. J., Goldberg, I. D., and Rosen, E. M. (2000). The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3′ kinase. Oncogene 19, 2212-2223.
10. Filippatos, G. S., Gangopadhyay, N., Lalude, O., Parameswaran, N., Said, S. I., Spielman, W., and Uhal, B. D. (2001). Regulation of apoptosis by vasoactive peptides. Am. J. Physiol. Lung Cell Mol. Physiol. 281, L749-L761.
11. Hackett, T. L., Holloway, R., Holgate, S. T., and Warner, J. A. (2008). Dynamics of pro-inflammatory and anti-inflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo study. Respir. Res. 9, 47.
12. Horiuchi, M., Hayashida, W., Kambe, T., Yamada, T., and Dzau, V. J. (1997). Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J. Biol. Chem. 272, 19022-19026.
13. Ito, T., Deng, X., Carr, B., and May, W. S. (1997). Bcl-2 phosphorylation required for anti-apoptosis function. J. Biol. Chem. 272, 11671-11673.
14. Kawaida, K., Matsumoto, K., Shimazu, H., and Nakamura, T. (1994). Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc. Natl. Acad. Sci. USA 91, 4357-4361.
15. Kinnard, W. V., Tuder, R., Papst, P., and Fisher, J. H. (1994). Regulation of alveolar type II cell differentiation and proliferation in adult rat lung explants. Am. J. Respir. Cell. Mol. Biol. 11, 416-425.
16. Kito, S., Shimizu, K., Okamura, H., Yoshida, K., Morimoto, H., Fujita, M., Morimoto, Y., Ohba, T., and Haneji, T. (2003). Cleavage of nucleolin and argyrophilic nucleolar organizer region associated proteins in apoptosis-induced cells. Biochem. Biophys. Res. Commun. 300, 950-956.
17. Kitta, K., Day, R. M., Ikeda, T., and Suzuki, Y. J. (2001). Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis. Free Radic. Biol. Med. 31, 902-910.
18. Konigshoff, M., Wilhelm, A., Jahn, A., Sedding, D., Amarie, O. V., Eul, B., Seeger, W., Fink, L., Gunther, A., Eickelberg, O., and Rose, F. (2007). The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis. Am. J. Respir. Cell. Mol. Biol. 37, 640-650.
19. Kosai, K., Matsumoto, K., Funakoshi, H., and Nakamura, T. (1999). Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology 30, 151-159.
20. Krown, K. A., Page, M. T., Nguyen, C., Zechner, D., Gutierrez, V., Comstock, K. L., Glembotski, C. G., Quintana, P.J.E., and Sabbadini, R. A. (1996). Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. J. Clin Invest. 98, 2854-2865.
21. Lang, D. S., Droemann, D., Schultz, H., Branscheid, D., Martin, C., Ressmeyer, A. R., Zabel, P., Vollmer, E., and Goldmann, T. (2007). A novel human ex vivo model for the analysis of molecular events during lung cancer chemotherapy. Respir. Res. 8, 43
22. Lee, Y. H., Mungunsukh, O., Tutino, R. L., Marquez, A. P., and Day, R. M. (2010). Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells. J. Cell Sci. 123, 1634-1643.
23. Lee, Y. H., Suzuki, Y. J., Griffin, A. J., and Day, R. M. (2008). Hepatocyte growth factor regulates cyclooxygenase-2 expression via beta-catenin, Akt, and p42/p44 MAPK in human bronchial epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 294, L778-L786.
24. Li, X., Rayford, H., and Uhal, B. D. (2003). Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice. Am. J. Pathol. 163, 2523-2530.
25. Mancini, G. B., and Khalil, N. (2005). Angiotensin II type 1 receptor blocker inhibits pulmonary injury. Clin. Invest. Med. 28, 118-126.
26. Marshall, R. P., Gohlke, P., Chambers, R. C., Howell, D. C., Bottoms, S. E., Unger, T., McAnulty, R. J., and Laurent, G. J. (2004). Angiotensin II and the fibroproliferative response to acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 286, L156-L164.
27. Matsumoto, K., and Nakamura, T. (1993). Roles of HGF as a pleiotropic factor in organ regeneration. EXS 65, 225-249.
28. Matsumoto, K., and Nakamura, T. (2001). Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int. 59, 2023-2038. (Pubitemid 32467594)
29. Otake, Y., Soundararajan, S., Sengupta, T. K., Kio, E. A., Smith, J. C., Pineda- Roman, M., Stuart, R. K., Spicer, E. K., and Fernandes, D. J. (2007). Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood 109, 3069-3075.
30. Peter, M., Nakagawa, J., Doree, M., Labbe, J. C., and Nigg, E. A. (1990). Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase. Cell 60, 791-801.
31. Ponzetto, C., Bardelli, A., Zhen, Z., Maina, F., dalla Zonca, P., Giordano, S., Graziani, A., Panayotou, G., and Comoglio, P. M. (1994). A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77, 261-271.
32. Rubin, J. S., Bottaro, D. P., and Aaronson, S. A. (1993). Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim. Biophys. Acta 1155, 357-371.
33. Schwab, M. S., and Dreyer, C. (1997). Protein phosphorylation sites regulate the function of the bipartite NLS of nucleolin. Eur. J. Cell Biol. 73, 287-297.
34. Sengupta, T. K., Bandyopadhyay, S., Fernandes, D. J., and Spicer, E. K. (2004). Identification of nucleolin as an AU-rich element binding protein involved in bcl-2 mRNA stabilization. J. Biol. Chem. 279, 10855-10863.
35. Srivastava, M., and Pollard, H. B. (1999). Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J. 13, 1911-1922.
36. Ugrinova, I., Monier, K., Ivaldi, C., Thiry, M., Storck, S., Mongelard, F., and Bouvet, P. (2007). Inactivation of nucleolin leads to nucleolar disruption, cell cycle arrest and defects in centrosome duplication. BMC Mol. Biol. 8, 66
37. Umeda, J., Sano, S., Kogawa, K., Motoyama, N., Yoshikawa, K., Itami, S., Kondoh, G., Watanabe, T., and Takeda, J. (2003). In vivo cooperation between Bcl-xL and the phosphoinositide 3-kinase-Akt signaling pathway for the protection of epidermal keratinocytes from apoptosis. FASEB J. 17, 610-620.
38. Wang, R., Ibarra-Sunga, O., Verlinski, L., Pick, R., and Uhal, B. D. (2000). Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am. J. Physiol. Lung Cell Mol. Physiol. 279, L143-L151.
39. Wang, R., Ramos, C., Joshi, I., Zagariya, A., Pardo, A., Selman, M., and Uhal, B. D. (1999a). Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides. Am. J. Physiol. Lung Cell Mol. Physiol. 277, L1158-L1164.
40. Wang, R., Zagariya, A., Ibarra-Sunga, O., Gidea, C., Ang, E., Deshmukh, S., Chaudhary, G., Baraboutis, J., Filippatos, G., and Uhal, B. D. (1999b). Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 276, L885-L889.
41. Watanabe, M., et al. (2005). Hepatocyte growth factor gene transfer to alveolar septa for effective suppression of lung fibrosis. Mol. Ther. 12, 58-67.
42. Wynn, T. A. (2008). Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199-210.
43. Xiao, G. H., Jeffers, M., Bellacosa, A., Mitsuuchi, Y., Vande Woude, G. F., and Testa, J. R. (2001). Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proc. Natl. Acad. Sci. USA 98, 247-252.
44. Yaekashiwa, M., Nakayama, S., Ohnuma, K., Sakai, T., Abe, T., Satoh, K., Matsumoto, K., Nakamura, T., Takahashi, T., and Nukiwa, T. (1997). Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am. J. Respir. Crit. Care Med. 156, 1937-1944.
45. Zhang, J., Tsaprailis, G., and Bowden, G. T. (2008a). Nucleolin stabilizes Bcl-X L messenger RNA in response to UVA irradiation. Cancer Res. 68, 1046-1054.
46. Zhang, J., Yang, J., and Liu, Y. (2008b). Role of Bcl-xL induction in HGF-mediated renal epithelial cell survival after oxidant stress. Int. J. Clin. Exp. Pathol. 1, 242-253.
47. Zhang, Y. W., and Vande Woude, G. F. (2003). HGF/SF-met signaling in the control of branching morphogenesis and invasion. J. Cell. Biochem. 88, 408-417.